Expand ANNX Menu
ANNX MENU

ANNX Latest Press Releases

-- August 10, 2026 --

Annexon Appoints Renowned Retinal Surgeon and Biotechnology Entrepreneur Mark S. Blumenkranz, M.D., M.M.S. to its Board of Directors Globe Newswire 4:05 PM

-- August 6, 2026 --

Annexon Reports First U.S. and European Patient Cohort of GBS FORWARD Study Demonstrated Rapid, Positive Clinical Responses in All Tanruprubart Treated Patients Within One Week Globe Newswire 8:00 AM

-- July 30, 2026 --

Annexon Secures Strategic Credit Facility for up to $200 Million from Oxford Finance Globe Newswire 4:01 PM

-- July 16, 2026 --

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- July 14, 2026 --

Annexon to Present Phase 2 ARCHER Baseline Characteristics Associated with Confirmed Best Corrected Visual Acuity 15-Letter Loss in Patients with Geographic Atrophy at ASRS 2026 Globe Newswire 4:05 PM

-- June 16, 2026 --

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- May 27, 2026 --

Annexon to Participate in Upcoming June Investor Conferences Globe Newswire 8:00 AM

-- May 18, 2026 --

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- May 11, 2026 --

110 Years. 110 Stories. 110 Reasons to Raise Awareness for GBS Globe Newswire 10:00 AM

-- May 7, 2026 --

Annexon Reports First Quarter 2026 Financial Results, Portfolio Progress and Key Anticipated Milestones Globe Newswire 4:01 PM

-- May 6, 2026 --

Annexon to Present at the Bank of America Securities Health Care Conference 2026 Globe Newswire 8:00 AM

-- April 8, 2026 --

Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference Globe Newswire 4:05 PM

-- March 30, 2026 --

Annexon Reports Fourth Quarter and Year-End 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones Globe Newswire 4:01 PM

-- March 16, 2026 --

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM
Market Data Delayed 15 Minutes